Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INTEGRATE: Ibrutinib plus prednisone vs placebo plus prednisone in new-onset chronic graft-versus-host disease
jRCT2080223879Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Apr 2018
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in chronic graft-versus-host disease (cGVHD) comparing Ibrutinib + prednisone with Placebo + prednisone (2 arms). Started Apr 2018; status: completed.
02
Drugs
ibrutinib
03
Conditions
chronic graft-versus-host disease (cGVHD)
Beyond the preview
Go deeper on jRCT2080223879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223879.